Synopsis
Synopsis
0
CEP/COS
0
EU WC
0
VMF
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
Annual Reports
NA
1. 5 Aminolaevulinate
2. 5 Aminolevulinate
3. 5-aminolaevulinate
4. 5-aminolevulinate
5. Acid Hydrochloride, Aminolevulinic
6. Acid, Aminolevulinic
7. Acid, Delta-aminolevulinic
8. Aminolevulinic Acid
9. Aminolevulinic Acid Hydrochloride
10. Delta Aminolevulinic Acid
11. Delta-aminolevulinic Acid
12. Hydrochloride, Aminolevulinic Acid
13. Levulan
1. 5451-09-2
2. Aminolevulinic Acid Hydrochloride
3. Levulan
4. 5-amino-4-oxopentanoic Acid Hydrochloride
5. Levulan Kerastick
6. 5-aminolevulinic Acid Hcl
7. Gliolan
8. Aminolevulinic Acid Hcl
9. Ameluz
10. Delta-aminolevulinic Acid Hydrochloride
11. Mfcd00012869
12. Alaglio
13. Gleolan
14. Alabel
15. Pentanoic Acid, 5-amino-4-oxo-, Hydrochloride
16. 5-aminolevulinic Acid, Hcl
17. 5-aminolevulinic Acid (hydrochloride)
18. 5-aminolevulinate Hydrochloride
19. 5-ala
20. Nsc-18509
21. V35kbm8jgr
22. 5-aminolevulinic Acid Hydrochloride Salt
23. .delta.-aminolevulinic Acid Hydrochloride
24. 5-amino-4-oxopentanoic Acid;hydrochloride
25. Npc-07
26. (4-carboxy-2-oxobutyl)azanium;chloride
27. 5-amino-4-oxopentanoic Acid Hcl
28. Aminolevulinic Acid Hydrochloride [usan]
29. Ncgc00095111-01
30. Dsstox_cid_25914
31. Dsstox_rid_81222
32. Dsstox_gsid_45914
33. 5-amino-4-oxopentanoic Acid Hydrochloride;5-amino-4-oxopentanoic Acid
34. Cas-5451-09-2
35. 5-amino-levulinic Acid Hydrochloride
36. 5-aminolevulinic Acid Hydrochloride, >=97.0% (at)
37. Alacare
38. Ala Hydrochloride
39. Einecs 226-679-5
40. Gleolan (tn)
41. Levulan (tn)
42. Ameluz (tn)
43. Nsc 18509
44. Ala Hcl
45. Ala-pdt
46. Levulinic Acid, 5-amino-, Hydrochloride
47. Unii-v35kbm8jgr
48. 5-amino-3-oxopentanoic Acid (hydrochloride)
49. 5-aminolevulinic Acid.hcl
50. Ala;5-ala
51. Pentanoic Acid, Hydrochloride
52. 5-amino-4-keto-valeric Acid
53. Schembl192308
54. Spectrum1504184
55. Chembl1200582
56. Dtxsid5045914
57. Chebi:132969
58. Hms1922f13
59. Pd-p-506-a
60. Pharmakon1600-01504184
61. 5 Ala Hcl (trivial Name)
62. Act05562
63. Bcp02161
64. Hy-n0305
65. Nsc18509
66. 5-amino Levulinic Acid Hydrochloride
67. Tox21_111426
68. Ccg-39079
69. Nsc758687
70. Akos015904495
71. Aminolevulinic Acid Hcl [inci]
72. Tox21_111426_1
73. Ac-4252
74. Bcp9000174
75. Gs-3020
76. Nsc-758687
77. 4-carboxy-2-oxobutan-1-aminium Chloride
78. 5-aminolevulinic Acid Hydrochloride, Gmp
79. Ncgc00095111-02
80. Ncgc00095111-03
81. Ncgc00178086-03
82. 5451-09-2 (hcl)
83. Sy017972
84. Db-005367
85. 5-aminolevulinic Acid Hydrochloride, >=98%
86. A0325
87. Am20100341
88. S2553
89. Sw218068-2
90. Aminolevulinic Acid Hydrochloride (jan/usan)
91. A-6100
92. A-6102
93. A-6103
94. A-6105
95. Aminolevulinic Acid Hydrochloride [jan]
96. D02908
97. Aminolevulinic Acid Hydrochloride [mart.]
98. 451a092
99. Aminolevulinic Acid Hydrochloride [usp-rs]
100. Aminolevulinic Acid Hydrochloride [who-dd]
101. .delta.-aminolevulinic Acid Hydrochloride [mi]
102. 5-aminolevulinic Acid Hydrochloride [ema Epar]
103. Aminolevulinic Acid Hydrochloride [orange Book]
104. Q27291473
105. Aminolevulinic Acid Hydrochloride [usp Monograph]
106. 0c1e43db-1221-4963-bfa4-18d3170000a4
107. 5-aminolevulinic Acid Hydrochloride, Particle Size < 0.25 Mm
108. Aminolevulinic Acid Hydrochloride Component Of Sonala001
109. Aminolevulinic Acid Hydrochloride Component Of Sonala-001
110. 5-aminolevulinic Acid Hydrochloride, Bioreagent, Suitable For Cell Culture, Powder, >=98%
111. Aminolevulinic Acid Hcl; Aminolevulinic Acid Hydrochloride;ala; 5-ala;aminolevulinic Acid
112. Aminolevulinic Acid Hydrochloride, United States Pharmacopeia (usp) Reference Standard
Molecular Weight | 167.59 g/mol |
---|---|
Molecular Formula | C5H10ClNO3 |
Hydrogen Bond Donor Count | 3 |
Hydrogen Bond Acceptor Count | 4 |
Rotatable Bond Count | 4 |
Exact Mass | 167.0349209 g/mol |
Monoisotopic Mass | 167.0349209 g/mol |
Topological Polar Surface Area | 80.4 Ų |
Heavy Atom Count | 10 |
Formal Charge | 0 |
Complexity | 121 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 2 |
1 of 2 | |
---|---|
Drug Name | Levulan |
PubMed Health | Aminolevulinic Acid (On the skin) |
Drug Classes | Photosensitizing Agent |
Active Ingredient | Aminolevulinic acid hydrochloride |
Dosage Form | Solution |
Route | Topical |
Strength | 20% |
Market Status | Prescription |
Company | Dusa |
2 of 2 | |
---|---|
Drug Name | Levulan |
PubMed Health | Aminolevulinic Acid (On the skin) |
Drug Classes | Photosensitizing Agent |
Active Ingredient | Aminolevulinic acid hydrochloride |
Dosage Form | Solution |
Route | Topical |
Strength | 20% |
Market Status | Prescription |
Company | Dusa |
Treatment of actinic keratosis of mild to moderate severity on the face and scalp (Olsen grade 1 to 2; see section 5. 1) and of field cancer ization in adults.
Treatment of superficial and/or nodular basal cell carcinoma unsuitable for surgical treatment due to possible treatment-related morbidity and/or poor cosmetic outcome in adults.
Gliolan is indicated in adult patients for visualisation of malignant tissue during surgery for malignant glioma (World Health Organization grade III and IV).
Photosensitizing Agents
Drugs that are pharmacologically inactive but when exposed to ultraviolet radiation or sunlight are converted to their active metabolite to produce a beneficial reaction affecting the diseased tissue. These compounds can be administered topically or systemically and have been used therapeutically to treat psoriasis and various types of neoplasms. (See all compounds classified as Photosensitizing Agents.)
L01XD04
L01XD04
API Imports and Exports
Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
---|
Upgrade, download data, analyse, strategize, subscribe with us
RLD : Yes
TE Code :
AMINOLEVULINIC ACID HYDROCHLORIDE
Brand Name : AMELUZ
Dosage Form : GEL;TOPICAL
Dosage Strength : 10%
Approval Date : 2016-05-10
Application Number : 208081
RX/OTC/DISCN : RX
RLD : Yes
TE Code :
RLD : Yes
TE Code :
AMINOLEVULINIC ACID HYDROCHLORIDE
Brand Name : GLEOLAN
Dosage Form : FOR SOLUTION;ORAL
Dosage Strength : 1.5GM/VIAL
Approval Date : 2017-06-06
Application Number : 208630
RX/OTC/DISCN : RX
RLD : Yes
TE Code :
RLD : Yes
TE Code :
AMINOLEVULINIC ACID HYDROCHLORIDE
Brand Name : LEVULAN
Dosage Form : SOLUTION;TOPICAL
Dosage Strength : 20%
Approval Date : 1999-12-03
Application Number : 20965
RX/OTC/DISCN : RX
RLD : Yes
TE Code :
Regulatory Info :
Registration Country : Sweden
aminolevulinic acid hydrochloride
Brand Name : Ameluz
Dosage Form : GEL
Dosage Strength : 78 MG / G
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Sweden
Regulatory Info :
Registration Country : Norway
Brand Name : Ameluz
Dosage Form : Gel
Dosage Strength : 78 mg/g
Packaging : Tube
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Norway
Regulatory Info :
Registration Country : Sweden
aminolevulinic acid hydrochloride
Brand Name : Alacare
Dosage Form : MEDICAL PATCH
Dosage Strength : 8 MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Sweden
Regulatory Info :
Registration Country : Switzerland
Aminolaevulinatis hydrochloridum
Brand Name : Alacare
Dosage Form : Pfl
Dosage Strength : 8mg
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Switzerland
Regulatory Info :
Registration Country : Switzerland
Aminolaevulinatis hydrochloridum
Brand Name : Alacare
Dosage Form : Pfl
Dosage Strength : 8mg
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Switzerland
Regulatory Info :
Registration Country : Switzerland
Brand Name : Ameluz
Dosage Form : Gel
Dosage Strength : 78mg/g
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Switzerland
Regulatory Info :
Registration Country : Sweden
aminolevulinic acid hydrochloride
Brand Name : Gliolan
Dosage Form : POWDER FOR ORAL SOLUTION
Dosage Strength : 30 MG / ML
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Sweden
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Regulatory Info :
Registration Country : Norway
Brand Name : Gliolan
Dosage Form : Powder for potion, resolution
Dosage Strength : 30 mg/ml
Packaging : Hood glass
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Norway
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Regulatory Info : Prescription
Registration Country : Canada
AMINOLEVULINIC ACID HYDROCHLORIDE
Brand Name : LEVULAN KERASTICK
Dosage Form : POWDER FOR SOLUTION
Dosage Strength : 20%
Packaging : 1.5ML
Approval Date :
Application Number : 2243933
Regulatory Info : Prescription
Registration Country : Canada
Regulatory Info : Prescription
Registration Country : Canada
AMINOLEVULINIC ACID HYDROCHLORIDE
Brand Name : GLEOLAN
Dosage Form : POWDER FOR SOLUTION
Dosage Strength : 1.5G/VIAL
Packaging :
Approval Date :
Application Number : 2504928
Regulatory Info : Prescription
Registration Country : Canada
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Related Excipient Companies
Excipients by Applications
Dosage Form : Cream / Lotion / Ointment, Suspension, Solution, Syrup
Grade : Topical, Oral
Category : Rheology Modifiers, Thickeners and Stabilizers, Topical
Dosage Form : Cream / Lotion / Ointment
Grade : Topical
Category : Emulsifying Agents, Solubilizers, Surfactant & Foaming Agents, Topical
Dosage Form : Capsule, Cream / Lotion / Ointment, Emulsion, Gel, Injectable / Parenteral, Suspension, Tablet
Grade : Parenteral, Oral, Topical
Category : Emulsifying Agents, Film Formers & Plasticizers, Parenteral, Solubilizers, Surfactant & Foaming Agents, Thickeners and Stabilizers, Topical
Application : Emulsifying Agents, Film Formers & Plasticizers, Parenteral, Solubilizers, Surfactant & Foaming Agents, Thickeners and Stabilizers, Topical
Excipient Details : Polysorbate 80 is used as a plasticizer, solubilizer, emulsifier, surfactant, and suspension stabilizer. It is also used in parenteral products.
Dosage Form : Cream / Lotion / Ointment, Suspension, Solution, Syrup
Grade : Topical, Oral
Category : Rheology Modifiers, Thickeners and Stabilizers, Topical
Dosage Form : Cream / Lotion / Ointment, Gel, Injectable / Parenteral, Softgels
Grade : Parenteral, Oral, Topical
Category : Film Formers & Plasticizers, Parenteral, Thickeners and Stabilizers, Topical
Dosage Form : Capsule, Cream / Lotion / Ointment
Grade : Topical and Oral
Category : Film Formers & Plasticizers, Topical
Application : Film Formers & Plasticizers, Topical
Dosage Form : Cream / Lotion / Ointment, Gel, Solution
Grade : Oral, Topical
Category : Emulsifying Agents, Solubilizers, Topical
Application : Emulsifying Agents, Solubilizers, Topical
Excipient Details : Hydrosol 50 is used as a solubilizer and emulsifying agent in oral and topical liquid and semi-solid dosage forms.
Pharmacopoeia Ref : USP/NF
Technical Specs : N/A
Ingredient(s) : Polyoxyl 40 Hydrogenated Castor Oil
Dosage Form : Capsule, Cream / Lotion / Ointment, Suspension, Tablet
Grade : Oral, Topical & Parenteral
Category : Solubilizers, Surfactant & Foaming Agents
Application : Solubilizers, Surfactant & Foaming Agents
Excipient Details : Polysorbate 80 acts as solubilizer, emulsifier and wetting agent.
Dosage Form : Capsule, Cream / Lotion / Ointment, Emulsion, Gel, Paste, Shampoo, Solution, Syrup, Tablet
Grade : Topical, Oral
Category : Film Formers & Plasticizers, Solubilizers, Surfactant & Foaming Agents, Topical
Brand Name : MONTANOX 80 PHA PREMIUM
Application : Film Formers & Plasticizers, Solubilizers, Surfactant & Foaming Agents, Topical
Excipient Details : Non-Ionic Hydrophilic Surfactant, Emulsifier, Solubilizer
Pharmacopoeia Ref : Ph.Eur, USP-NF
Technical Specs : HLB: 15, EO: 20; EXCiPACT
Ingredient(s) : Polysorbate 80
Application : Solubilizers, Topical
Excipient Details : Oil fill & solubilizer for lipophilic drugs, Water barrier-repairing, emollient film-former on skin
Pharmacopoeia Ref : Ph. Eur., USP/NF
Technical Specs : Not Available
Ingredient(s) : Medium Chain Triglycerides
Global Sales Information
Market Place
Reply
02 Sep 2022
Reply
25 Jun 2020
Reply
27 Mar 2017
Reply
05 Jan 2018
Patents & EXCLUSIVITIES
Patent Expiration Date : 2028-02-07
AMINOLEVULINIC ACID HYDROCHLORIDE
US Patent Number : 11540981
Drug Substance Claim :
Drug Product Claim : Y
Application Number : 208081
Patent Use Code :
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2028-02-07
Patent Expiration Date : 2040-10-15
AMINOLEVULINIC ACID HYDROCHLORIDE
US Patent Number : 11235169
Drug Substance Claim :
Drug Product Claim :
Application Number : 208081
Patent Use Code : U-3303
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2040-10-15
Patent Expiration Date : 2038-01-12
AMINOLEVULINIC ACID HYDROCHLORIDE
US Patent Number : 11077192
Drug Substance Claim :
Drug Product Claim :
Application Number : 20965
Patent Use Code : U-3163
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2038-01-12
Patent Expiration Date : 2038-01-12
AMINOLEVULINIC ACID HYDROCHLORIDE
US Patent Number : 11690914
Drug Substance Claim :
Drug Product Claim :
Application Number : 20965
Patent Use Code : U-3163
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2038-01-12
Patent Expiration Date : 2038-01-12
AMINOLEVULINIC ACID HYDROCHLORIDE
US Patent Number : 11135293
Drug Substance Claim :
Drug Product Claim :
Application Number : 20965
Patent Use Code : U-3163
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2038-01-12
Patent Expiration Date : 2038-01-12
AMINOLEVULINIC ACID HYDROCHLORIDE
US Patent Number : 11571478
Drug Substance Claim :
Drug Product Claim :
Application Number : 20965
Patent Use Code : U-3163
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2038-01-12
Patent Expiration Date : 2038-01-12
AMINOLEVULINIC ACID HYDROCHLORIDE
US Patent Number : 10357567
Drug Substance Claim :
Drug Product Claim :
Application Number : 20965
Patent Use Code : U-3163
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2038-01-12
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
LOOKING FOR A SUPPLIER?